These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10334556)

  • 21. Why nurses must get involved in colorectal cancer management.
    Melville A
    Nurs Times; 1998 Mar 18-24; 94(11):56-8. PubMed ID: 9697535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced colorectal cancer: quality of life and toxicity in patients after weekly 24-hour continuous infusions of biomodulated 5-fluorouracil.
    Bogliolo G; Pannacciulli I; Desalvo L; Barsotti B; Lerza R; Mencoboni M; Arboscello E
    Anticancer Res; 2000; 20(1B):501-4. PubMed ID: 10769713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose infusional 5-FU in the treatment of advanced colorectal cancer: a summary of the European experience.
    Wils JA
    J Infus Chemother; 1996; 6(3):145-8. PubMed ID: 9229327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized clinical trials in advanced and metastatic colorectal carcinoma.
    Dangelica MI; Shoup MC; Nissan A
    Surg Oncol Clin N Am; 2002 Jan; 11(1):173-91, ix. PubMed ID: 11928799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
    Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P;
    J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical modulation of fluoropyrimidines: is there an optimal (6R,S) leucovorin dose and schedule?
    Doroshow JH
    J Natl Cancer Inst; 1996 Apr; 88(7):393-5. PubMed ID: 8618231
    [No Abstract]   [Full Text] [Related]  

  • 29. Introduction. Beyond 5-fluorouracil.
    Pazdur R
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):15-6. PubMed ID: 10442352
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of advanced colorectal cancer.
    O'Dwyer PJ; Stevenson JP
    Cancer Treat Res; 1998; 98():111-52. PubMed ID: 10326667
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy for advanced colorectal cancer.
    Michael M; Zalcberg JR
    BMJ; 2000 Sep; 321(7260):521-2. PubMed ID: 10968797
    [No Abstract]   [Full Text] [Related]  

  • 32. European experience with irinotecan plus fluorouracil/folinic acid or mitomycin.
    Khayat D; Gil-Delgado M; Antoine EC; Coeffic D; Benhammouda A; Grapin JP; Bastian G
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):64-7. PubMed ID: 9726094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME; McGarry W; Bready B; Dakhil SR; Belt RJ; Goodwin JW; Gray R; Hoff PM; Winn R; Pazdur R
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
    Cascino TL; Veeder MH; Buckner JC; O'Fallon JR; Wiesenfeld M; Levitt R; Goldberg RM; Kuross SA; Morton RF; Scheithauer BW
    J Neurooncol; 1996 Dec; 30(3):243-6. PubMed ID: 8943099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy.
    Fountzilas G; Gossios K; Zisiadis A; Svarna E; Skarlos D; Pavlidis N
    Med Pediatr Oncol; 1996 May; 26(5):305-17. PubMed ID: 8614363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irinotecan may extend survival in people with metastatic colorectal cancer.
    Oncology (Williston Park); 1998 Oct; 12(10):1512. PubMed ID: 9798204
    [No Abstract]   [Full Text] [Related]  

  • 38. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
    J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
    Makower D; Wadler S
    Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy.
    Waters JS; Cunningham D
    Lancet; 2000 Oct; 356(9237):1276. PubMed ID: 11072976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.